Novel Risk Assessment Tool for Immunoglobulin Resistance in Kawasaki Disease

Abstract

The RF classifier reliably identified KD patients at high risk for IVIG resistance, presenting clinical markers relevant to treatment failure. Evaluation in other patient populations is required to determine whether this risk assessment tool relying on RF has clinical value.